CLRO
ClearOne, Inc.
There isn't enough reported data to score CLRO yet.
INTC
Intel Corporation
INTC lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve, though they disagree widely on how much.
CLRO Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Unavailable | |
| Unavailable |
CLRO's revenue and profitability are currently weak. There isn't enough data to rate its cash flow and balance sheet.
INTC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Healthy | |
| Healthy |
INTC's revenue, cash flow and balance sheet are currently healthy, but its profitability is under pressure.
CLRO PE Valuation
CLRO has no meaningful PE right now: it lost money over the past year.
INTC PE Valuation
INTC has no meaningful PE right now: it lost money over the past year.
CLRO Forward outlook
There aren't enough analyst estimates for CLRO to show an outlook.
INTC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Broad | |
| Low |
Analysts expect earnings and revenue growth for INTC, with profitability improving. However, they disagree widely on these estimates.
CLRO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.34 | +$10.07 |
| Q2 2026 | -$11.00 | -$4.16 |
| Q1 2026 | -$13.30 | -$7.30 |
| Q4 2025 | -$14.77 | -$9.22 |
| Q3 2025 | -$13.41 | -$10.71 |
| Q2 2025 | -$6.84 | -$4.59 |
| Q1 2025 | -$6.00 | -$4.95 |
| Q4 2024 | -$5.55 | -$5.25 |
CLRO lost $3.34 per share over the past year, a smaller loss than the year before.
INTC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.41 | — |
| Q3 2026 | -$2.39 | -24000% |
| Q2 2026 | -$2.09 | +$2.68 |
| Q1 2026 | -$0.60 | +$3.88 |
| Q4 2025 | -$0.06 | +$4.32 |
| Q3 2025 | $0.01 | +$3.72 |
| Q2 2025 | -$4.77 | -2088% |
| Q1 2025 | -$4.48 | -562% |
| Q4 2024 | -$4.38 | -1195% |
INTC has the edge over CLRO on earnings, with more consistent year-over-year improvement.
CLRO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2025 | $1.9M | -17% |
| Q1 2025 | $2.3M | -36% |
| Q4 2024 | $3M | -29% |
| Q3 2024 | $2.5M | -49% |
| Q2 2024 | $2.3M | -58% |
| Q1 2024 | $3.6M | -13% |
| Q4 2023 | $4.2M | +3.3% |
| Q3 2023 | $4.9M | -22% |
CLRO's revenue has slid since its 2020 peak: $0 last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2025 | -238% | -111 points |
| Q1 2025 | -123% | -66 points |
| Q4 2024 | -68% | -27 points |
| Q3 2024 | -87% | -57 points |
| Q2 2024 | -127% | -102 points |
| Q1 2024 | -57% | -5 points |
| Q4 2023 | -42% | +23 points |
| Q3 2023 | -30% | -12 points |
CLRO's operating margin was −238% last quarter, down 111 points from the same quarter a year ago, near the bottom of its range since 2019.
INTC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $16.5B | +21% |
| Q2 2026 | $16.1B | +25% |
| Q1 2026 | $13.6B | +7.2% |
| Q4 2025 | $13.7B | -4.1% |
| Q3 2025 | $13.7B | +2.8% |
| Q2 2025 | $12.9B | +0.2% |
| Q1 2025 | $12.7B | -0.4% |
| Q4 2024 | $14.3B | -7.4% |
INTC has the edge over CLRO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +10 points |
| Q2 2026 | 11% | +36 points |
| Q1 2026 | -23% | -21 points |
| Q4 2025 | 4.2% | +1.4 points |
| Q3 2025 | 5% | +73 points |
| Q2 2025 | -25% | -9.4 points |
| Q1 2025 | -2.4% | +6 points |
| Q4 2024 | 2.9% | -14 points |
INTC's operating margin was 15% last quarter, up 10 points from the same quarter a year ago.
CLRO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$905K | +$224K |
| Q1 2026 | -$680K | +$776K |
| Q4 2025 | -$11.2M | -$9.7M |
| Q3 2025 | -$754K | +$1.1M |
| Q2 2025 | -$1.1M | +$2.1M |
| Q1 2025 | -$1.5M | -500% |
| Q4 2024 | -$1.6M | -145% |
| Q3 2024 | -$1.9M | -$50K |
CLRO has burned cash in most quarters: −$14M over the past year, against −$6M the year before.
INTC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.1B | +774% |
| Q2 2026 | $4.5B | +$6B |
| Q1 2026 | -$2.5B | +$1.8B |
| Q4 2025 | $800M | +$3.5B |
| Q3 2025 | $121M | +$2.5B |
| Q2 2025 | -$1.5B | +$1.9B |
| Q1 2025 | -$4.4B | +$2.8B |
| Q4 2024 | -$2.7B | -$597M |
INTC has the edge over CLRO on cash generation, producing positive trailing cash flow while its opponent burns cash.
CLRO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | +54% | +942K shares |
| 3 years | +68% | +1.1M shares |
| 5 years | +114% | +1.4M shares |
| Available history | +141% | +1.6M shares |
CLRO has 3M diluted shares, up 54% from a year ago.
INTC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4% | +203M shares |
| 1 year | +17% | +776M shares |
| 3 years | +25% | +1.1B shares |
| 5 years | +30% | +1.2B shares |
| Available history | +19% | +834M shares |
INTC has the edge over CLRO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | $114M |
| Q1 2021 | $2.3B |
CLRO Net Leverage
CLRO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
INTC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.0x | Healthy |
| Q2 2026 | 3.1x | Elevated |
| Q1 2026 | 3.9x | Elevated |
| Q4 2025 | 3.4x | Elevated |
| Q3 2025 | 4.0x | Elevated |
| Q1 2025 | 69.6x | High |
| Q3 2024 | 23.8x | High |
| Q2 2024 | 4.3x | High |
INTC's net debt is about 2.0 years of its operating earnings (EBITDA), down from 4.0 years a year ago.
CLRO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.0 | Neutral |
| Stochastic | 18.8 | Oversold |
CLRO's weekly RSI is 46 (neutral) and its Stochastic is 19 (oversold).
INTC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.1 | Neutral |
| Stochastic | 7.7 | Oversold |
INTC's weekly RSI is 38 (neutral) and its Stochastic is 8 (oversold).
CLRO PE vs Technology Sector
| Metric | CLRO | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
CLRO has no meaningful PE right now: it lost money over the past year.
INTC PE vs Technology Sector
| Metric | INTC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
INTC has no meaningful PE right now: it lost money over the past year.
CLRO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.70 | 5.9% below |
| 20 week MA | $5.08 | 31% below |
| 50 week MA | $4.74 | 27% below |
| 100 week MA | $5.94 | 41% below |
| 200 week MA | $10.2 | 66% below |
CLRO is in a downtrend: it's below all five of its weekly moving averages, and 66% below its 200-week average.
INTC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $88.4 | 31% below |
| 20 week MA | $95.3 | 36% below |
| 50 week MA | $79.3 | 23% below |
| 100 week MA | $52.1 | 18% above |
| 200 week MA | $42.5 | 44% above |
INTC has the edge over CLRO on trend strength, trading above more of its moving averages.
CLRO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $26.3 | $37.2 | +42% |
| 2021 | $37.2 | $20.0 | -46% |
| 2022 | $20.0 | $23.1 | +16% |
| 2023 | $23.1 | $16.2 | -30% |
| 2024 | $16.2 | $9.13 | -44% |
| 2025 | $9.13 | $5.33 | -42% |
| 2026 YTD | $5.33 | $3.48 | -35% |
CLRO has finished three years in a row lower, and it's down 35% so far in 2026.
INTC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $60.1 | $47.1 | -22% |
| 2021 | $47.1 | $51.3 | +9% |
| 2022 | $51.3 | $26.1 | -49% |
| 2023 | $26.1 | $50.3 | +93% |
| 2024 | $50.3 | $20.3 | -60% |
| 2025 | $20.3 | $36.2 | +78% |
| 2026 YTD | $36.2 | $61.2 | +69% |
INTC has the edge over CLRO on returns for 2026, with the stronger performance.